Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes

Bone

Volumn 72, Issue , 2015, Pages 34-42

  Chia, Ling Yeong ^a,b   Walsh, Nicole C ^a,b   Martin, T John ^a,b   Sims, Natalie A ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Osteoclast; Osteocyte

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; CD11B ANTIGEN; CD2 ANTIGEN; CD31 ANTIGEN; CD3E ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CELL MARKER; DENDRITIC CELL SPECIFIC TRANSMEMBRANE PROTEIN; DENTIN MATRIX PROTEIN 1; GR1 PROTEIN; GREEN FLUORESCENT PROTEIN; KERATOCAN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MESSENGER RNA; OSTEOCLAST ASSOCIATED RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; SCLEROSTIN; TER119 PROTEIN; UNCLASSIFIED DRUG; ACID PHOSPHATASE; DMP1 PROTEIN, MOUSE; ISOENZYME; SCLEROPROTEIN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEMATOPOIETIC CELL; ISOLATION AND PURIFICATION; MACROPHAGE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; OSTEOBLAST; PHENOTYPE;

ACID PHOSPHATASE; ANIMALS; CATHEPSIN K; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; EXTRACELLULAR MATRIX PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; ISOENZYMES; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; PHENOTYPE; RANK LIGAND; RECEPTORS, CALCITONIN;

EID: 84912095590     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.11.005     Document Type: Article

References (61)

1. Bonewald L.F. Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci 2007, 1116:281-290.
2. Schaffler M.B., Cheung W.Y., Majeska R., Kennedy O. Osteocytes: master orchestrators of bone. Calcif Tissue Int 2014, 94:5-24.
3. Poole K.E., van Bezooijen R.L., Loveridge N., Hamersma H., Papapoulos S.E., Lowik C.W., et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005, 19:1842-1844.
4. Leupin O., Piters E., Halleux C., Hu S., Kramer I., Morvan F., et al. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. J Biol Chem 2011, 286:19489-19500.
5. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006, 38:1310-1315.
6. Lorenz-Depiereux B., Bastepe M., Benet-Pages A., Amyere M., Wagenstaller J., Muller-Barth U., et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006, 38:1248-1250.
7. Bergwitz C., Juppner H. FGF23 and syndromes of abnormal renal phosphate handling. Adv Exp Med Biol 2012, 728:41-64.
8. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J.Q., et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011, 17:1231-1234.
9. Vashishth D., Verborgt O., Divine G., Schaffler M.B., Fyhrie D.P. Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone 2000, 26:375-380.
10. Verborgt O., Gibson G.J., Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 2000, 15:60-67.
11. Cardoso L., Herman B.C., Verborgt O., Laudier D., Majeska R.J., Schaffler M.B. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 2009, 24:597-605.
12. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O'Brien C.A. Matrix-embedded cells control osteoclast formation. Nat Med 2011, 17:1235-1241.
13. Nijweide P.J., Mulder R.J. Identification of osteocytes in osteoblast-like cell cultures using a monoclonal antibody specifically directed against osteocytes. Histochemistry 1986, 84:342-347.
14. Westbroek I., De Rooij K.E., Nijweide P.J. Osteocyte-specific monoclonal antibody MAb OB7.3 is directed against Phex protein. J Bone Miner Res 2002, 17:845-853.
15. Mikuni-Takagaki Y., Kakai Y., Satoyoshi M., Kawano E., Suzuki Y., Kawase T., et al. Matrix mineralization and the differentiation of osteocyte-like cells in culture. J Bone Miner Res 1995, 10:231-242.
16. Kawata A., Mikuni-Takagaki Y. Mechanotransduction in stretched osteocytes-temporal expression of immediate early and other genes. Biochem Biophys Res Commun 1998, 246:404-408.
17. van der Plas A., Aarden E.M., Feijen J.H., de Boer A.H., Wiltink A., Alblas M.J., et al. Characteristics and properties of osteocytes in culture. J Bone Miner Res 1994, 9:1697-1704.
18. Aarden E.M., Wassenaar A.M., Alblas M.J., Nijweide P.J. Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes. Histochem Cell Biol 1996, 106:495-501.
19. Halleux C., Kramer I., Allard C., Kneissel M. Isolation of mouse osteocytes using cell fractionation for gene expression analysis. Methods Mol Biol 2012, 816:55-66.
20. Stern A.R., Stern M.M., Van Dyke M.E., Jahn K., Prideaux M., Bonewald L.F. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 2012, 52:361-373.
21. Toyosawa S., Shintani S., Fujiwara T., Ooshima T., Sato A., Ijuhin N., et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 2001, 16:2017-2026.
22. Kalajzic I., Braut A., Guo D., Jiang X., Kronenberg M.S., Mina M., et al. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 2004, 35:74-82.
23. Paic F., Igwe J.C., Nori R., Kronenberg M.S., Franceschetti T., Harrington P., et al. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 2009, 45:682-692.
24. Torreggiani E., Matthews B.G., Pejda S., Matic I., Horowitz M.C., Grcevic D., et al. Preosteocytes/osteocytes have the potential to dedifferentiate becoming a source of osteoblasts. PLoS One 2013, 8:e75204.
25. Fumoto T., Takeshita S., Ito M., Ikeda K. Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis. J Bone Miner Res 2014, 29:830-842.
26. Qing H., Ardeshirpour L., Pajevic P.D., Dusevich V., Jahn K., Kato S., et al. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res 2012, 27:1018-1029.
27. Gooi J.H., Chia L.Y., Walsh N.C., Karsdal M.A., Quinn J.M.W., Martin T.J., et al. Decline in calcitonin receptor expression in osteocytes with age. J Endocrinol 2014, 221:181-191.
28. Gooi J.H., Pompolo S., Karsdal M.A., Kulkarni N.H., Kalajzic I., McAhren S.H., et al. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 2010, 46:1486-1497.
29. Ota K., Quint P., Ruan M., Pederson L., Westendorf J.J., Khosla S., et al. Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization. J Cell Biochem 2013, 114:1901-1907.
30. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234.
31. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005, 106:3020-3027.
32. Rybtsov S., Sobiesiak M., Taoudi S., Souilhol C., Senserrich J., Liakhovitskaia A., et al. Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region. J Exp Med 2011, 208:1305-1315.
33. Pearce D.J., Ridler C.M., Simpson C., Bonnet D. Multiparameter analysis of murine bone marrow side population cells. Blood 2004, 103:2541-2546.
34. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
35. Singbrant S., Russell M.R., Jovic T., Liddicoat B., Izon D.J., Purton L.E., et al. Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood 2011, 117:5631-5642.
36. Allan E.H., Hausler K.D., Wei T., Gooi J.H., Quinn J.M., Crimeen-Irwin B., et al. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res 2008, 23:1170-1181.
37. Takyar F.M., Tonna S., Ho P.W., Crimeen-Irwin B., Baker E.K., Martin T.J., et al. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. J Bone Miner Res 2013, 28:912-925.
38. Le Goff B., Singbrant S., Tonkin B.A., Martin T.J., Romas E., Sims N.A., et al. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts. Cytokine 2014, 68:101-109.
39. Nakamura A., Ly C., Cipetic M., Sims N.A., Vieusseux J., Kartsogiannis V., et al. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Bone 2007, 40:305-315.
40. Parkinson I.H., Fazzalari N.L., Durbridge T.C., Moore A.J. Simplified approach to enzymatic identification of osteoclastic bone resorption. J Histotechnol 1991, 14:81-83.
41. Balic A., Mina M. Identification of secretory odontoblasts using DMP1-GFP transgenic mice. Bone 2011, 48:927-937.
42. Igwe J.C., Jiang X., Paic F., Ma L., Adams D.J., Baldock P.A., et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem 2009, 108:621-630.
43. Li H., Marijanovic I., Kronenberg M.S., Erceg I., Stover M.L., Velonis D., et al. Expression and function of Dlx genes in the osteoblast lineage. Dev Biol 2008, 316:458-470.
44. Kondoh S., Inoue K., Igarashi K., Sugizaki H., Shirode-Fukuda Y., Inoue E., et al. Estrogen receptor alpha in osteocytes regulates trabecular bone formation in female mice. Bone 2014, 60:68-77.
45. Bivi N., Nelson M.T., Faillace M.E., Li J., Miller L.M., Plotkin L.I. Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone. Calcif Tissue Int 2012, 91:215-224.
46. Balic A., Aguila H.L., Mina M. Identification of cells at early and late stages of polarization during odontoblast differentiation using pOBCol3.6GFP and pOBCol2.3GFP transgenic mice. Bone 2010, 47:948-958.
47. Powell W.F., Barry K.J., Tulum I., Kobayashi T., Harris S.E., Bringhurst F.R., et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol 2011, 209:21-32.
48. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005, 202:345-351.
49. Barrow A.D., Raynal N., Andersen T.L., Slatter D.A., Bihan D., Pugh N., et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest 2011, 121:3505-3516.
50. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of Cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
51. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B., et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 1996, 122:3151-3162.
52. Belanger L.F., Robichon J., Migicovsky B.B., Copp D.H., Vincent J. Resorption without osteoclasts (osteolysis). Mechanisms of hard tissue destruction 1963, 531-556. American Association for the, Advancement of Science, Washington, D.C.
53. Hoff A.O., Catala-Lehnen P., Thomas P.M., Priemel M., Rueger J.M., Nasonkin I., et al. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 2002, 110:1849-1857.
54. Dacquin R., Davey R.A., Laplace C., Levasseur R., Morris H.A., Goldring S.R., et al. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 2004, 164:509-514.
55. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999, 265:144-150.
56. Soderstrom K., Stein E., Colmenero P., Purath U., Muller-Ladner U., de Matos C.T., et al. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A 2010, 107:13028-13033.
57. Li H., Jiang X., Delaney J., Franceschetti T., Bilic-Curcic I., Kalinovsky J., et al. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 2010, 176:2405-2413.
58. Kusu N., Laurikkala J., Imanishi M., Usui H., Konishi M., Miyake A., et al. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 2003, 278:24113-24117.
59. Loots G.G., Kneissel M., Keller H., Baptist M., Chang J., Collette N.M., et al. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res 2005, 15:928-935.
60. Terasawa M., Shimokawa R., Terashima T., Ohya K., Takagi Y., Shimokawa H. Expression of dentin matrix protein 1 (DMP1) in nonmineralized tissues. J Bone Miner Metab 2004, 22:430-438.
61. Ogbureke K.U., Fisher L.W. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 2005, 68:155-166.